Incannex Healthcare Inc. SEC filings IXHL

Incannex Healthcare Inc. has 266 filings in SEC EDGAR's recent list, going back to Aug 17, 2021. Its latest annual report, Form ARS, was filed on Oct 28, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 15, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 9, 2026 (regulation fd disclosure). The company's fiscal year ends on June 30.

Incannex Healthcare Inc. SEC filings
Form Description Filed Period
ARS Annual report to shareholders Oct 28, 2026 Jun 30, 2026
DEFA14A Additional proxy material Oct 28, 2026 —
DEF 14A Proxy statement Oct 28, 2026 Dec 17, 2026
10-K Annual report Sep 25, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure
Sep 9, 2026 Sep 9, 2026
8-K Current report
Regulation FD disclosure
Aug 25, 2026 Aug 25, 2026
8-K Current report
Regulation FD disclosure
Aug 11, 2026 Aug 11, 2026
8-K Current report
Regulation FD disclosure
Jul 23, 2026 Jul 23, 2026
8-K Current report
Regulation FD disclosure
Jun 25, 2026 Jun 25, 2026
8-K Current report
Regulation FD disclosure
Jun 10, 2026 Jun 10, 2026
8-K Current report
Regulation FD disclosure
Jun 9, 2026 Jun 9, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Regulation FD disclosure
May 14, 2026 May 14, 2026
8-K Current report
Regulation FD disclosure
May 12, 2026 May 12, 2026
8-K Current report
Regulation FD disclosure
Apr 22, 2026 Apr 22, 2026
8-K Current report
Regulation FD disclosure
Mar 27, 2026 Mar 27, 2026
8-K Current report
Regulation FD disclosure
Mar 25, 2026 Mar 25, 2026
8-K Current report
Regulation FD disclosure
Mar 18, 2026 Mar 18, 2026
8-K Current report
Listing notice, Other events
Mar 17, 2026 Mar 16, 2026
424B5 Prospectus supplement Mar 12, 2026 —
8-K Current report
Material agreement, Other events
Mar 12, 2026 Mar 12, 2026
8-K Current report
Agreement ended, Regulation FD disclosure, Other events
Mar 12, 2026 Mar 11, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Feb 25, 2026 Feb 24, 2026
10-Q Quarterly report Feb 13, 2026 Dec 31, 2025
8-K Current report
Other events
Jan 29, 2026 Jan 29, 2026
8-K Current report
Other events
Jan 22, 2026 Jan 22, 2026
8-K Current report
Shareholder vote results
Jan 16, 2026 Jan 15, 2026
8-K Current report
Other events
Jan 15, 2026 Jan 15, 2026
8-K Current report
Other events
Jan 14, 2026 Jan 14, 2026
8-K Current report
Other events
Dec 18, 2025 Dec 18, 2025
DEFA14A Additional proxy material Dec 18, 2025 —
DEFA14A Additional proxy material Dec 16, 2025 —
8-K Current report
Other events
Dec 3, 2025 Dec 3, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
S-8 Employee stock plan registration Nov 14, 2025 —
8-K Current report
Other events
Oct 30, 2025 Oct 30, 2025
ARS Annual report to shareholders Oct 27, 2025 Jun 30, 2025
DEFA14A Additional proxy material Oct 27, 2025 —
DEF 14A Proxy statement Oct 27, 2025 Dec 18, 2025
8-K Current report
Other events
Oct 22, 2025 Oct 22, 2025
8-K Current report
Listing notice
Oct 22, 2025 Oct 21, 2025
10-K Annual report Sep 29, 2025 Jun 30, 2025
8-K Current report
Other events
Aug 26, 2025 Aug 26, 2025
8-K Current report
Other events
Aug 22, 2025 Aug 22, 2025
8-K Current report
Other events
Aug 8, 2025 Aug 8, 2025
8-K Current report
Other events
Jul 31, 2025 Jul 31, 2025
8-K Current report
Other events
Jul 30, 2025 Jul 30, 2025
8-K Current report
Other events
Jul 25, 2025 Jul 25, 2025
8-K Current report
Other events
Jul 24, 2025 Jul 24, 2025
424B5 Prospectus supplement Jul 24, 2025 —
S-3MEF Registration statement Jul 24, 2025 —
8-K Current report
Other events
Jun 24, 2025 Jun 24, 2025
8-K Current report
Other events
Jun 18, 2025 Jun 18, 2025
8-K Current report
Other events
Jun 17, 2025 Jun 17, 2025
8-K Current report
Listing notice
Jun 13, 2025 Jun 11, 2025
8-K Current report
Other events
Jun 12, 2025 Jun 12, 2025
S-8 Employee stock plan registration Jun 4, 2025 —
8-K Current report
Other events
Jun 3, 2025 Jun 3, 2025
8-K Current report
Other events
May 29, 2025 May 29, 2025
8-K Current report
Other events
May 28, 2025 May 28, 2025
424B5 Prospectus supplement May 28, 2025 —
8-K Current report
Material agreement, Agreement ended, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
May 28, 2025 May 27, 2025
8-K Current report
Other events
May 20, 2025 May 20, 2025
8-K Current report
Other events
May 20, 2025 May 20, 2025
424B5 Prospectus supplement May 20, 2025 —
8-K Current report
Other events
May 16, 2025 May 16, 2025
DEFA14A Additional proxy material May 16, 2025 —
8-K Current report
Material agreement
May 15, 2025 May 15, 2025
8-K Current report
Other events
May 15, 2025 May 15, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Other events
May 14, 2025 May 14, 2025
UPLOAD Letter from the SEC Apr 29, 2025 —
EFFECT Filing Apr 28, 2025 —
424B3 Prospectus Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 May 27, 2025
8-K Current report
Listing notice, Other events
Apr 25, 2025 Apr 23, 2025
CORRESP Letter to the SEC Apr 24, 2025 —
PRER14A Revised preliminary proxy statement Apr 17, 2025 —
S-1/A Amended registration statement Apr 16, 2025 —
CORRESP Letter to the SEC Apr 16, 2025 —
8-K Current report
Material agreement
Apr 7, 2025 Apr 7, 2025
424B5 Prospectus supplement Apr 7, 2025 —
8-K Current report
Other events
Apr 3, 2025 Apr 3, 2025
UPLOAD Letter from the SEC Apr 2, 2025 —
UPLOAD Letter from the SEC Apr 2, 2025 —
S-3 Shelf registration Mar 24, 2025 —
PRE 14A Preliminary proxy statement Mar 18, 2025 Mar 18, 2025
8-K Current report
Material agreement, Agreement ended, New debt
Mar 18, 2025 Mar 13, 2025
D Filing Mar 17, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Mar 10, 2025 Mar 7, 2025
8-K Current report
Other events
Feb 14, 2025 Feb 14, 2025
10-Q Quarterly report Feb 14, 2025 Dec 31, 2024
8-K Current report
Other events
Feb 4, 2025 Feb 4, 2025
8-K Current report
Other events
Jan 23, 2025 Jan 23, 2025
8-K Current report
Listing notice
Jan 10, 2025 Jan 3, 2025
8-K Current report
Shareholder vote results
Dec 11, 2024 Dec 11, 2024
EFFECT Filing Dec 6, 2024 —
424B3 Prospectus Dec 6, 2024 —
CORRESP Letter to the SEC Dec 4, 2024 —
S-1/A Amended registration statement Nov 26, 2024 —
EFFECT Filing Nov 22, 2024 —
CORRESP Letter to the SEC Nov 20, 2024 —
UPLOAD Letter from the SEC Nov 15, 2024 —
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
UPLOAD Letter from the SEC Nov 13, 2024 —
ARS Annual report to shareholders Nov 12, 2024 Jun 30, 2024
DEF 14A Proxy statement Nov 12, 2024 Dec 11, 2024
S-3 Shelf registration Nov 6, 2024 —
S-3 Shelf registration Nov 6, 2024 —
PRE 14A Preliminary proxy statement Oct 31, 2024 Oct 31, 2024
8-K Current report
Other events
Oct 24, 2024 Oct 24, 2024
8-K Current report
Officer or director change
Oct 24, 2024 Oct 21, 2024
8-K Current report
New debt, Unregistered share sale
Oct 21, 2024 Oct 17, 2024
8-K Current report
Material agreement
Oct 15, 2024 Oct 9, 2024
8-K Current report
Other events
Sep 30, 2024 Sep 30, 2024
10-K Annual report Sep 30, 2024 Jun 30, 2024
8-K Current report
Other events
Sep 10, 2024 Sep 10, 2024
8-K Current report
Material agreement
Sep 10, 2024 Sep 9, 2024
RW Withdrawal request Sep 10, 2024 —
8-K Current report
Other events
Aug 5, 2024 Aug 5, 2024
8-K Current report
Other events
Jul 30, 2024 Jul 30, 2024
S-1/A Amended registration statement Jul 17, 2024 —
S-1 Registration statement Jul 3, 2024 —
8-K Current report
Other events
May 30, 2024 May 30, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Other events
May 7, 2024 May 7, 2024
8-K Current report
Other events
Apr 16, 2024 Apr 16, 2024
8-K Current report
Officer or director change
Mar 5, 2024 Feb 29, 2024
8-K Current report
Other events
Feb 28, 2024 Feb 28, 2024
8-K Current report
Other events
Feb 16, 2024 Feb 16, 2024
10-Q Quarterly report Feb 14, 2024 Dec 31, 2023
8-K Current report
Other events
Feb 1, 2024 Feb 1, 2024
8-K Current report
Other events
Jan 24, 2024 Jan 24, 2024
8-K Current report
Other events
Jan 18, 2024 Jan 18, 2024
8-K Current report
Other events
Jan 17, 2024 Jan 17, 2024
8-K Current report
Other events
Dec 22, 2023 Dec 21, 2023
S-8 Employee stock plan registration Dec 20, 2023 —
8-K Current report
Auditor change
Dec 15, 2023 Dec 14, 2023
EFFECT Filing Nov 30, 2023 —
8-K Current report
Material agreement, Listing notice, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
Nov 29, 2023 Nov 28, 2023
POS AM Post-effective amendment no. 1 to form f-3 Nov 29, 2023 —
15-12G Deregistration Nov 29, 2023 —
25-NSE/A Filing Nov 29, 2023 —
25-NSE Delisting notice Nov 28, 2023 —
6-K Current report (foreign issuer) Nov 24, 2023 Nov 23, 2023
6-K Current report (foreign issuer) Nov 20, 2023 Nov 17, 2023
6-K Current report (foreign issuer) Nov 17, 2023 Nov 17, 2023
6-K Current report (foreign issuer) Nov 17, 2023 Nov 17, 2023
6-K Current report (foreign issuer) Nov 16, 2023 Nov 16, 2023
6-K Current report (foreign issuer) Nov 8, 2023 Nov 8, 2023
6-K Current report (foreign issuer) Nov 7, 2023 Nov 7, 2023
20-F Annual report (foreign issuer) Oct 31, 2023 Jun 30, 2023
6-K Current report (foreign issuer) Oct 26, 2023 Oct 26, 2023
6-K Current report (foreign issuer) Oct 19, 2023 Oct 19, 2023
6-K Current report (foreign issuer) Oct 10, 2023 Oct 10, 2023
6-K Current report (foreign issuer) Oct 5, 2023 Oct 5, 2023
6-K Current report (foreign issuer) Sep 8, 2023 Sep 8, 2023
6-K Current report (foreign issuer) Sep 1, 2023 Sep 1, 2023
6-K Current report (foreign issuer) Sep 1, 2023 Aug 30, 2023
6-K Current report (foreign issuer) Aug 24, 2023 Aug 24, 2023
6-K Current report (foreign issuer) Aug 22, 2023 Aug 22, 2023
6-K Current report (foreign issuer) Aug 10, 2023 Aug 10, 2023
6-K Current report (foreign issuer) Aug 8, 2023 Aug 8, 2023
6-K Current report (foreign issuer) Aug 1, 2023 Aug 1, 2023
6-K Current report (foreign issuer) Jul 28, 2023 Jul 28, 2023
6-K Current report (foreign issuer) Jul 26, 2023 Jul 26, 2023
6-K Current report (foreign issuer) Jul 21, 2023 Jul 21, 2023
6-K Current report (foreign issuer) Jul 18, 2023 Jul 18, 2023
6-K Current report (foreign issuer) Jul 13, 2023 Jul 13, 2023
6-K Current report (foreign issuer) Jul 10, 2023 Jul 10, 2023
6-K Current report (foreign issuer) Jul 6, 2023 Jul 6, 2023
6-K Current report (foreign issuer) Jun 30, 2023 Jun 30, 2023
6-K Current report (foreign issuer) Jun 23, 2023 Jun 23, 2023
6-K Current report (foreign issuer) Jun 16, 2023 Jun 16, 2023
6-K Current report (foreign issuer) Jun 7, 2023 Jun 7, 2023
6-K Current report (foreign issuer) May 30, 2023 May 30, 2023
6-K Current report (foreign issuer) May 30, 2023 May 30, 2023
6-K Current report (foreign issuer) May 18, 2023 May 18, 2023
6-K Current report (foreign issuer) May 5, 2023 May 5, 2023
6-K Current report (foreign issuer) May 3, 2023 May 3, 2023
6-K Current report (foreign issuer) May 2, 2023 May 2, 2023
6-K Current report (foreign issuer) Apr 27, 2023 Apr 27, 2023
6-K Current report (foreign issuer) Apr 14, 2023 Apr 14, 2023
6-K Current report (foreign issuer) Mar 16, 2023 Mar 16, 2023
6-K Current report (foreign issuer) Mar 15, 2023 Mar 15, 2023
EFFECT Filing Mar 13, 2023 —
CORRESP Letter to the SEC Mar 9, 2023 —
UPLOAD Letter from the SEC Mar 8, 2023 —
6-K Current report (foreign issuer) Mar 3, 2023 Mar 3, 2023
F-3 Shelf registration (foreign issuer) Mar 2, 2023 —
6-K Current report (foreign issuer) Feb 28, 2023 Feb 28, 2023
6-K Current report (foreign issuer) Feb 27, 2023 Dec 31, 2022
6-K Current report (foreign issuer) Jan 27, 2023 Jan 27, 2023
6-K Current report (foreign issuer) Dec 5, 2022 Dec 5, 2022
6-K Current report (foreign issuer) Dec 1, 2022 Dec 1, 2022
6-K Current report (foreign issuer) Nov 29, 2022 Nov 29, 2022
6-K Current report (foreign issuer) Nov 25, 2022 Nov 25, 2022
6-K Current report (foreign issuer) Nov 21, 2022 Nov 21, 2022
6-K Current report (foreign issuer) Nov 17, 2022 Nov 17, 2022
20-F Annual report (foreign issuer) Oct 28, 2022 Jun 30, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IXHL (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Norwest Nsw
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1873875
Former names
Incannex Healthcare Ltd (until Nov 29, 2023)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.